Gerhard Gründer
Gerhard Gründer
Professor of Psychiatry, Central Institute of Mental Health
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ...
Pharmacopsychiatry 44 (6), 195-235, 2011
Kompendium der psychiatrischen Pharmakotherapie
O Benkert, H Hippius, I Anghelescu, E Davids, G Gründer, ...
Springer, 2013
Correlation Between Dopamine D2 Receptors in the Ventral Striatum and Central Processing of Alcohol Cues and Craving
A Heinz, T Siessmeier, J Wrase, D Hermann, S Klein, ...
American Journal of Psychiatry 161 (10), 1783-1789, 2004
Drug interactions at GABAA receptors
ER Korpi, G Gründer, H Lüddens
Progress in neurobiology 67 (2), 113-159, 2002
Dopamine D 2 and D 3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11 C …
F Yokoi, G Gründer, K Biziere, M Stephane, AS Dogan, RF Dannals, ...
Neuropsychopharmacology 27 (2), 248-259, 2002
Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women
KN Spreckelmeyer, S Krach, G Kohls, L Rademacher, A Irmak, K Konrad, ...
Social cognitive and affective neuroscience 4 (2), 158-165, 2009
Correlation of Alcohol Craving With Striatal Dopamine Synthesis Capacity and D2/3 Receptor Availability: A Combined [18F]DOPA and [18F]DMFP PET Study in …
A Heinz, T Siessmeier, J Wrase, HG Buchholz, G Gründer, Y Kumakura, ...
American Journal of Psychiatry 162 (8), 1515-1520, 2005
Dissociation of neural networks for anticipation and consumption of monetary and social rewards
L Rademacher, S Krach, G Kohls, A Irmak, G Gründer, KN Spreckelmeyer
Neuroimage 49 (4), 3276-3285, 2010
Mechanism of new antipsychotic medications: occupancy is not just antagonism
G Gründer, A Carlsson, DF Wong
Archives of general psychiatry 60 (10), 974-977, 2003
Association of Low Striatal Dopamine D 2 Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse
C Fehr, I Yakushev, N Hohmann, HG Buchholz, C Landvogt, H Deckers, ...
American Journal of Psychiatry 165 (4), 507-514, 2008
Oxytocin plasma concentrations after single intranasal oxytocin administration–a study in healthy men
A Gossen, A Hahn, L Westphal, S Prinz, RT Schultz, G Gründer, ...
Neuropeptides 46 (5), 211-215, 2012
Dopamine in amygdala gates limbic processing of aversive stimuli in humans
T Kienast, AR Hariri, F Schlagenhauf, J Wrase, P Sterzer, HG Buchholz, ...
Nature neuroscience 11 (12), 1381-1382, 2008
Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain
SE Groppe, A Gossen, L Rademacher, A Hahn, L Westphal, G Gründer, ...
Biological psychiatry 74 (3), 172-179, 2013
The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans
M Schreckenberger, C Lange-Asschenfeld, M Lochmann, K Mann, ...
Neuroimage 22 (2), 637-644, 2004
The'atypicality'of antipsychotics: a concept re-examined and re-defined
G Gründer, H Hippius, A Carlsson
Nature Reviews Drug Discovery 8 (3), 197-202, 2009
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology–a double-blind controlled study comparing a selective D2-like antagonist to a mixed …
H Wetzel, G Gründer, A Hillert, M Philipp, WF Gattaz, H Sauer, G Adler, ...
Psychopharmacology 137 (3), 223-232, 1998
Elevated [18F] fluorodopamine turnover in brain of patients with schizophrenia: an [18F] fluorodopa/positron emission tomography study
Y Kumakura, P Cumming, I Vernaleken, HG Buchholz, T Siessmeier, ...
Journal of Neuroscience 27 (30), 8080-8087, 2007
The role of imaging in proof of concept for CNS drug discovery and development
DF Wong, J Tauscher, G Gründer
Neuropsychopharmacology 34 (1), 187-203, 2009
A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia
O Benkert, G Gründer, H Wetzel, D Hackett
Journal of psychiatric research 30 (6), 441-451, 1996
Therapeutic monitoring of new antipsychotic drugs
C Hiemke, A Dragicevic, G Gründer, S Hätter, J Sachse, I Vernaleken, ...
Therapeutic drug monitoring 26 (2), 156-160, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20